bcl-2 Suppresses Expression of p21WAF1/CIP1 in Breast Epithelial Cells

Cancer Research

Volumn 55, Issue 20, 1995, Pages 4520-4524

  Upadhyay, Sunil ^a   Li, Gangyong ^a   Liu, Hao ^a   Chen, Yong Q ^a   Sarkar, Fazlul H ^a   Kim, Hyeong Reh Choi ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; ONCOPROTEIN; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL CYCLE G1 PHASE; CELL TRANSFORMATION; CLONING VECTOR; CONTROLLED STUDY; DNA TRANSFECTION; ETIOLOGY; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BASE SEQUENCE; CELLS, CULTURED; CYCLINS; DNA PRIMERS; GENE EXPRESSION; GENES, P53; HUMAN; IN VITRO; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T;

EID: 0028972009     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Cross, M., and Dexter, T. M. Growth factors in development, transformation, and tumorigenesis. Cell, 64: 271–280, 1991.
2. McDonnell, T. J., Deane, N., Piatt, F. M., Nunes, G., Jaeger, U., McKearn, J. P., and Korsmeyer, S. J. Bcl-2-immunoglobulin transgenic mice demonstrate extended B-cell survivlal and follicular lymphoproliferation. Cell, 57: 79–88, 1989.
3. Strasser A., Harris, A. W., and Cory, S. Bcl-2 transgene inhibits T-cell death and perturbs thymic self-censorship. Cell, 67: 889–899, 1991.
4. White, E. Death-defying acts: a meeting review on apoptosis. Genes Dev., 7: 2277–2284, 1993.
5. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849–852, 1993.
6. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates cytotoxicity of anti-cancer agents. Cell, 74: 957–967, 1993.
7. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847–849, 1993.
8. Gujuluva, C. N., Baek, J.-H., Shin, K.-H., Cherrick, H. M., and Park, N.-H. Effect of UV-irradiation on cell cycle, viabilty, and the expression of p53, gadd 153, and gadd 45 genes in normal and HPV-immortalized human oral keratinocytes. Oncogene, 9: 1819–1827, 1994.
9. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391–3395, 1994.
10. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817–825, 1993.
11. El-Deiry, W. S., Harper, J. W., O′Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W., and Vogelstein, B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54: 1169–1174, 1994.
12. Xiong, Y., Zhang, H., and Beach, D. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell, 71: 505–514, 1992.
13. Xiong, Y., Zhang, H., and Beach, D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev., 7: 1572–1583, 1993.
14. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805–816, 1993.
15. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701–704, 1993.
16. Waga, S., Hannon, G., Beach, D., and Stillman, B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574–578, 1994.
17. Lane, D. P. Cancer. P53, guardian of the genome. Nature (Lond.), 358: 15–16, 1992.
18. Michalovitz, D., Halevy, O., and Oren, M. p53 mutations: gains or losses? Cell, 62: 671–680, 1990.
19. Tsujimoto, Y., Cossman, J., Jaffe, E., and Croce, C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science (Washington DC), 228: 1440–1143, 1985.
20. Tsujimoto, Y. Stress resistance conferred by high level of bcl-2 alpha protein in human B-lymphoblastoid cell. Oncogene, 4: 1331–1336, 1989.
21. Hockenbery, D. M., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334–336, 1990.
22. Miyashita, T., and Reed, J. C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81: 151–157, 1993.
23. Nunez, G., London, L., Hockenbery, D., Alexandra, M., McKearn, J. P., and Korsmeyer, S. J. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. Immunology, 144: 3602–3610, 1990.
24. Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., and Korsmeyer, S. L. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67: 879–888, 1991.
25. Vaux, D. L., Cory, S., and Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335: 440–442, 1988.
26. Walton, M. I., Whysong, D., O′Connor, P. M., Hockenbery, D., Korsmeyer, S. J., and Kohn, K. W. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res., 53: 1853–1861, 1993.
27. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609–619, 1993.
28. Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H. G., Krajewski, S., Reed, J. C., Hoffman, B., and Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene, 9: 1791–1798, 1994.
29. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9: 1799–1805, 1994.
30. Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., and Korsmeyer, S. J. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88: 6961–6965, 1991.
31. Croce, C. M., Erikson, J., Tsujimoto, Y., and Nowell, P. C. Molecular basis of human B and T cell neoplasia. In: G. Klein (ed.), Advances in Viral Oncology 7: pp 35–51. New York: Raven Press, 1987.
32. Silvestrini, R., Veneroni, S., Daidone, M. G., Benini, E., Boracchi, P., Mezzetti, M., Fronzo, G. Rilke, F., and Veronesi, U. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node negative breast cancer patients. J. Natl. Cancer Inst., 86: 499–504, 1994.
33. Soule H., Maloney, T. M., Wolman S. R., Peterspm, W. D., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6075–6086, 1990.
34. Tait, L., Soule, H. J., and Russo, J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50: 6087–6094, 1990.
35. Kim, H.-R.C., Upadhyay, S., Korsmeyer, S., and Deuel, T. F. Platelet derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell. J. Biol. Chem., 269: 30604–30608, 1994.
36. Kim, H.-R.C., Kennedy, B. S., and Engel, J. D. Two chicken erythrocyte band 3 mRNAs are generated by alternative transcriptional initiation and differential RNA splicing. Mol. Cell. Biol., 9: 5198–5206, 1989.
37. Sarkar, F. H., Valdivieso, M., Borders, J., Yao, K.-L., Raval, M. M. T., Madan, S. K., Sreepathi, P., Shimoyama, R., Steiger, Z., Cummings, G. D., and Crissman, J. D. A universal method for the mutational analysis of k-ras and p53 genes in non-small cell lung cancer using formalin-fixed, paraffin-embedded tissue. Diagn. Mol. Pathol., in press, 1995.
38. Deckwerth, T. L., and Johnson, E. M. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol., 123: 1207–1222, 1993.
39. Hall, P. A., McKee, P. H., Menage, H. D., Dover, R., and Lane, D. P. High levels of p53 protein in UV-irradiated normal human skin. Oncogene, 8: 203, 1993.
40. Li, R., Waga, S., Hannon, G. J., Beach, D., and Stillman, B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature (Lond.), 371: 534–537, 1994.
41. Hollstein, M., Sidransky, D., Vogelstein B., and Harris, C. p53 mutations in human cancers. Science (Washington DC), 253: 153–155, 1991.
42. Greenblatt, M. S., Bennett, W. P. Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855–4878, 1994.
43. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453–456, 1991.
44. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215–221, 1992.
45. Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F. J., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., and Friend, S. H. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233–1238, 1990.
46. Perry, M. E., Piette, J., Zawadzki, J. A. Harvey. D., and Levine, A. J. The mdm-2 gene is induced in repsonse to UV light in a p53 dependent manner. Proc. Natl. Acad. Sci. USA, 90: 11623–11627, 1993.
47. Momand, J., Zambetti, G., Olson, D. C., Goerge, D., and Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69: 1237–1245, 1992.
48. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391–3395, 1994.